Previous Article | Next Article 
Infect Immun, April 1998, p. 1534-1537, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Phlebotomus papatasi Saliva Inhibits
Protein Phosphatase Activity and Nitric Oxide Production by
Murine Macrophages
John
Waitumbi and
Alon
Warburg*
Department of Parasitology, The Kuvin Center
for the Study of Infectious and Tropical Diseases, Hebrew
University-Hadassah Medical School, Jerusalem, Israel
Received 20 October 1997/Returned for modification 25 November
1997/Accepted 8 January 1998
 |
ABSTRACT |
Leishmania parasites, transmitted by phlebotomine sand
flies, are obligate intracellular parasites of macrophages. The sand fly Phlebotomus papatasi is the vector of Leishmania
major, a causative agent of cutaneous leishmaniasis in the Old
World, and its saliva exacerbates parasite proliferation and lesion
growth in experimental cutaneous leishmaniasis. Here we show that
P. papatasi saliva contains a potent inhibitor of protein
phosphatase 1 and protein phosphatase 2A of murine macrophages. We
further demonstrate that P. papatasi saliva down regulates
expression of the inducible nitric oxide synthase gene and reduces
nitric oxide production in murine macrophages. Partial biochemical
characterization of the protein phosphatase and nitric oxide inhibitor
indicated that it is a small, ethanol-soluble molecule resistant to
boiling, proteolysis, and DNase and RNase treatments. We suggest that
the P. papatasi salivary protein phosphatase inhibitor
interferes with the ability of activated macrophages to transmit
signals to the nucleus, thereby preventing up regulation of the induced nitric oxide synthase gene and inhibiting the production of nitric oxide. Since nitric oxide is toxic to intracellular parasites, the
salivary protein phosphatase inhibitor may be the mechanism by which
P. papatasi saliva exacerbates cutaneous
leishmaniasis.
 |
INTRODUCTION |
The leishmaniases are sand fly-borne
parasitic diseases that affect large populations in the palaearctic and
tropical regions of the world (1). Two major disease types,
cutaneous and visceral, are recognized in humans. In cutaneous
leishmaniasis, parasites are restricted to dermal lesions that develop
at the site of the infectious bite and usually heal spontaneously
(29). In the visceral form, parasites invade the spleen,
liver, and bone marrow, causing a serious, life-threatening systemic
disease (3).
Sand flies become infected with leishmaniae when they ingest blood
containing parasitized macrophages (M
). In the alimentary canal of
the phlebotomine sand fly, leishmaniae transform into, and develop as
extracellular, flagellated promastigotes. They reproduce by binary
fission and go through a series of developmental stages culminating
with the generation of infective-stage metacyclic promastigotes that
are inoculated into the vertebrate host's skin as the female sand fly
sucks blood (21). Once in the skin, parasites rapidly invade
M
and replicate as intracellular amastigotes. Their entry into the
M
and survival inside the phagolysosome are made possible by a
number of strategies that subvert the M
's scavenger functions
(reviewed in references 8 and
14). Despite these qualities, experimental
inoculations with low doses of promastigotes fail to initiate
infections in susceptible mouse strains. However, when similarly small
numbers are inoculated by vector sand flies, infections flourish.
Higher efficiency of transmission by vectors is a result of parasites
being coinoculated with saliva.
Sand fly saliva has been shown to exacerbate experimental cutaneous
lesions caused by several different Leishmania species (22, 25, 27, 30). This is probably a result of saliva inhibiting antigen presentation and reducing nitric oxide (NO) production by Leishmania-infected M
(9, 26) or
enhancing interleukin-4 secretion by T lymphocytes (15).
Most of the salivary factor(s) responsible for these phenomena have not
been identified. One important molecule is undoubtedly maxadilan, a
potent vasodilator that facilitates blood feeding by sand flies
(13, 20). Maxadilan was also shown to modulate a number of
immune functions in mice (18). However, maxadilan is found
in the saliva of only one sand fly species, Lutzomyia
longipalpis. Phlebotomus papatasi saliva, which
exacerbates cutaneous leishmaniasis and reduces NO
production, lacks maxadilan (29a).
The capacity of M
to respond to activation signals against
intracellular pathogens during the nonimmune early phases of infection is crucial for determining whether the invading organisms proliferate or are eliminated (28). One strategy by which M
fight
invasive organisms is via the production of the cytotoxic molecule NO
(8, 14). In murine M
, the signaling process that leads to
the activation of the induced nitric oxide synthase (iNOS) gene, and
the subsequent production of NO is mediated by protein phosphatase 1 (PP-1) and PP-2A (4, 7). Here we report on the presence of a
potent PP-1 and PP-2A inhibitor in the saliva of P. papatasi and its ability to down regulate the iNOS gene expression
and inhibit NO production in activated murine M
.
 |
MATERIALS AND METHODS |
Reagents.
RPMI 1640 medium, fetal bovine serum, mouse
recombinant gamma interferon (IFN-
), okadaic acid (OA), the
protein phosphatase (PP) assay kit, and the RNA isolation kit were
purchased from GIBCO-BRL, Life Technologies. Ca2+- and
Mg2+-free Hanks balanced salt solution (HBSS) and
phenol-extracted Escherichia coli lipopolysaccharide (LPS)
were purchased from Sigma Chemical Co. (St. Louis, Mo.).
[
-32P]ATP (6,000 Ci/mmol) was purchased from Dupont
NEN (Boston, Mass.). The reverse transcriptase (RT)-mediated PCR
(RT-PCR) kit, Griess reagent, DNase I, and RNase A were purchased from
Promega Corporation.
Sand fly rearing and collection of salivary gland lysate.
P. papatasi was reared as described previously
(17). Salivary glands from 3- to 6-day-old sand flies were
dissected in Ca2+- and Mg2+-free HBSS and
stored at
70°C. Before use, the glands were disrupted by repeated
freeze-thawing in liquid nitrogen and centrifugation (10,000 × g for 2 min). Complete disruption was verified
microscopically, and the lysate was spun again at 10,000 × g to pellet any debris.
Mice.
Eight- to twelve-week-old C3H/HeN female mice were
maintained in a National Institutes of Health-approved sterile
pathogen-free animal facility.
Collection and culture of peritoneal exudate M
.
M
were
obtained from LPS-sensitive C3H/HeN inbred mice as described previously
(7). Briefly, mice were stimulated with 2.0 ml of 3%
thioglycolate injected intraperitoneally. Four days later, M
were
harvested by peritoneal lavage using 10 ml of RPMI 1640 (GIBCO-BRL),
washed in Ca2+- and Mg2+-free HBSS, and
resuspended in RPMI 1640 containing 1% fetal bovine serum;
106 cells/well in 1.0 ml were seeded in 24-well plates.
M
cultures were incubated at 37°C, 5% CO2, and 95%
humidity for 90 min. To remove nonadherent cells, cultures were washed
with serum-free RPMI 1640. Adherent M
were incubated in serum-free
RPMI 1640 containing M
activators or inhibitors as described below.
For assessing iNOS gene expression, M
were activated by incubation
for 8 h with LPS (25 ng/ml) and IFN-
(25 U/ml) with or without
saliva. For assessing NO production, activation of M
was achieved by
incubation for 24 h with LPS (1 µg/ml) alone.
In vitro PP assay.
About 2 × 107 adherent
M
were washed in Ca2+- and Mg2+-free HBSS
and lysed for 5 min on ice in 1 ml of lysis buffer (7). The cytoplasmic and nuclear fractions were separated by centrifugation at
1,000 × g for 2 min. The cytoplasmic fraction was
aliquoted and immediately frozen at
70°C. PP activity in the
extracts was determined (for 20 min at 34°C) by using a PP assay
system (GIBCO) according to the manufacturer's protocol. To
distinguish between release of 32Pi and
trichloroacetic acid-soluble 32P-labeled phosphopeptides,
the 32Pi was complexed to ammonium molybdate
and extracted with organic solvents (23). Various
concentrations of sand fly salivary gland lysates or OA were incubated
with M
extracts for 15 min at room temperature before the addition
of 32P-labeled phosphorylase A.
To calculate PP-1 and PP-2A activity, 1.0 nM OA was added to the assay
buffer. Since OA at this concentration totally inhibits PP-2A (50%
inhibitory concentration [IC50] = 0.2 nM) in dilute M
extracts (2), the reduction in PP activity was attributed to
PP-2A and the remaining activity was attributed to PP-1
(IC50 = 10 to 15 nM). To measure PP activity of the
Mg2+-dependent PP-2C, the assay buffer contained 1 mM EGTA
to inhibit PP-2B and contained 10 mM Mg2+ and 1 µM OA to
inhibit PP-1 and PP-2A. To measure the activity of the
Ca2+/calmodulin-dependent PP-2B, the assay buffer contained
0.1 mM Ca2+ and 0.5 µM OA.
Partial biochemical characterization of the PP-1 and PP-2A
inhibitor.
Salivary gland lysates were filtered in succession
through membranes with different molecular size cutoffs (Amicon,
Beverly, Mass.). The retentates and the filtrates were tested for
inhibition of PP-1 and PP-2A activity and NO production as described
above. To characterize the PP inhibitor component biochemically,
salivary gland lysates were subjected to one of the following
treatments: boiling for 10 min, proteolysis with trypsin (0.5 mg/ml)
and chymotrypsin (0.5 mg/ml) at pH 7.5 and 37°C for 1 h followed
by treatment with soybean trypsin inhibitor, proteolysis with
proteinase K (100 µg/ml) for 3 h at 37°C followed by boiling
for 10 min to inactivate the enzymes, or treatment with DNase 1 (10 U) and RNase A (10 µg/ml) at 37°C for 1 h. PP-1 and
PP-2A inhibition was assayed as described above. Controls comprised all
reaction components except the salivary gland lysates.
RNA isolation and RT-PCR.
Total cellular RNA was extracted
from control and treated cultures of M
by using a Trizol RNA
isolation kit (GIBCO). Synthesis of the first-strand cDNA and the
subsequent PCR were performed with an Access RT-PCR kit (Promega).
Sense and antisense primers for the constitutively expressed
hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene
and iNOS mRNA were located on different exons to facilitate detection
of possible contamination by genomic DNA (19). Two hundred
nanograms of total RNA was used in 25 µl of RT-PCR buffer containing
1 mM MgSO4, 0.2 mM deoxynucleoside triphosphates, 50 pmol
of sense and antisense primers, 1.25 U of avian myeloblastosis virus RT
enzyme, and 1.25 U of Taq DNA polymerase. Reverse
transcription was carried out at 48°C for 45 min followed by 40 amplification cycles of 94°C for 2 min, 60°C for 1 min, and 68°C
for 2 min in a Biometra Thermocycler. The PCR products were
electrophoresed on agarose gels and stained with ethidium bromide, and
the UV image was captured and analyzed by using NIH Image computer
graphics.
Nitrite analysis.
The concentration of
NO2
that accumulated in the M
culture
medium over 24 h was determined in a microplate assay using Griess reagent. Fifty microliters of the culture supernatant was mixed with an
equal amount of 1% sulfanilamide in 5% phosphoric acid and incubated
at room temperature for 5 min. Then 50 µl of 0.1% N-1-naphthylethylenediamine dihydrochloride in water was
added, and the mixture was incubated for an additional 5 min. The
absorbance at 550 nm was read with a microplate reader.
NO2
concentrations were determined by using
sodium nitrite as a standard.
 |
RESULTS AND DISCUSSION |
The M
cytosolic fraction exhibited high levels of PP activity,
and dephosphorylation of 32P-phosphorylase A increased
linearly up to a concentration of 40 µg of M
protein per ml (Fig.
1, inset). Four enzymes, PP-1, PP-2A,
PP-2B, and PP-2C, account for virtually all the phosphatase activity in
mammalian cells (11). These enzymes can be differentiated biochemically on the basis of their sensitivity to specific inhibitors and divalent cation dependency (2, 4, 5). For example, OA
reduces 50% of the PP-2A at a concentration of 0.2 nM
(IC50 = 0.2 nM); complete inhibition is achieved at 1 nM.
On the other hand, a 100-fold-higher concentration (10 to 15 nM) is
required to inhibit PP-1. PP-2B is a Ca2+-dependent PP and
is only weakly affected by OA. PP-2C is completely dependent on
Mg2+ for activity and is uninhibited by OA. Therefore, to
analyze the contribution of each of these four PPs to the total PP
activity, we treated the M
cytosolic fraction with various
concentrations of OA. At a concentration of 0.5 µM OA, in the
presence of Ca2+ or Mg2+, no PP activity was
detected, indicating that PP-2B and PP-2C were not significant
contributors to overall PP activity. The addition of 1.0 nM OA to the
M
cytosolic fraction inhibited activity by 21%. Since at this
concentration OA inhibits all of the PP-2A activity, the remaining 79%
was attributable to PP-1 (Fig. 2).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Inhibition of PP-1 and PP-2A activity by salivary
P. papatasi gland lysates. M cytosolic fraction
(12.5 µg/ml) was incubated with different concentrations of
salivary gland lysate for 15 min at room temperature, and PP activity
was assayed by using [ -32P]ATP-labeled
phosphorylase A as the substrate. Inset, PP activity from the
cytosolic fraction of C3H/HeN mice M as a function of
M -derived protein (1 mU = 1 nmol of phosphate
released from phosphorylase A/min/ml).
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
PP-1 and PP-2A activity in M cytosolic fraction.
Column 1 shows total PP activity in 250 ng of untreated M cytosolic
fraction; column 2 shows complete PP-1 and PP-2A inhibition by 0.5 µM
OA; column 3 shows PP-1 activity after inhibition of PP-2A with 1.0 nm
OA; column 4 shows remaining activity after addition of two
P. papatasi salivary glands (gln); column 5 shows PP-1
activity after addition of two glands and 1.0 nm OA. Data shown are
means ± standard deviations of three experiments.
|
|
P. papatasi saliva contains a powerful inhibitor
of PP-1 and PP-2A.
P. papatasi salivary gland lysates
from male as well as female flies inhibited PP-1 and PP-2A activity in
a dose-dependent manner (Fig. 1). An extract of two salivary glands (=1
µg of protein) was as potent as 12.5 nM OA (data not shown). To
measure inhibition of PP-1 activity by saliva, assays were conducted in
the presence of 1.0 nM OA and any inhibition below that produced by OA
was attributed to inhibition of PP-1 (Fig. 2). Controls included sand fly washing solution, HBSS, and material extruded from sand flies during dissection. None had any inhibitory effect on M
PP activity.
Protein phosphorylation and dephosphorylation reactions, mediated by
protein kinases and PPs, respectively, trigger signal transduction
events that control diverse cellular responses to both internal and
external signals (4, 10). Here we demonstrate that
P. papatasi saliva contains a potent, dose-dependent
inhibitor of PP-1 and PP-2A that is distinct from OA. While
PP-2A is significantly more sensitive to inhibition by OA
(2, 5), it is PP-1 that is more sensitive to P. papatasi saliva (Fig. 2). This is the first report demonstrating
the ability of a blood-sucking insect's saliva to specifically
interfere with protein phosphorylation, a key process in eukaryotic
cell signal transduction.
P. papatasi saliva inhibits expression of the iNOS
gene.
Levels of cellular NO are directly controlled by the
production of iNOS enzyme. This is because availability of NO cannot be
regulated by storage, release, or uptake (12). Indeed, in our experiments, normal resting M
did not express detectable levels
of iNOS mRNA (data not shown). However, once activated with
LPS, M
expressed very high levels of this gene (Fig.
3).

View larger version (123K):
[in this window]
[in a new window]
|
FIG. 3.
Inhibition of iNOS mRNA expression by salivary gland
lysates of P. papatasi. M were treated for 8 h
with IFN- (25 U/ml) and LPS (25 ng/ml) in the presence or absence of
saliva. Total RNA was extracted, subjected to RT-PCR, electrophoresed,
and analyzed by optical densitometry. Lanes 1 to 4, HPRT; lanes 5 to 8, iNOS. Lanes marked +S include saliva. Results are from one
representative experiment of three. M, size markers.
|
|
The signaling process for the activation of the iNOS gene and the
subsequent production of nitric oxide in murine M
is facilitated by
PP-1 and PP-2A (7). Since saliva of P. papatasi inhibited PP-1 and PP-2A (Fig. 1 and 2), we used RT-PCR
to examine whether expression of the iNOS gene in activated M
is
inhibited by saliva. Results show that the addition of one
P. papatasi salivary gland to 106 M
caused a 50% reduction in iNOS mRNA (Fig. 3). The housekeeping gene
HPRT was also amplified from each RNA preparation to enable comparisons of the PCR products in different samples.
P. papatasi saliva reduces NO production.
We
next examined whether the observed down regulation of the iNOS gene by
saliva would result in less NO being produced. M
were incubated in
serum-free RPMI 1640 containing IFN-
and LPS with or without saliva.
The NO2
concentration was measured after
24 h. As little as 0.5 gland/ml of P. papatasi
saliva caused a 30 to 40% reduction in NO2
secretion by M
activated with either Leishmania parasites
or LPS and IFN-
(Fig. 4).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Inhibition of PP activity (A) and NO production (B) by
whole P. papatasi saliva and by different size
fractions obtained by filtration through molecular size cutoff filters.
S, whole saliva; <3, <3-kDa filtrate; 100, 100-kDa retentate. (A)
PP-1 and PP-2A inhibition assays were performed with 250 ng of
untreated M cytosolic fraction and two gland equivalents per assay.
(B) For NO analysis, M (106 cells/ml/well) were
activated by using LPS in the presence of different fractions for
24 h. NO2 was assayed as described in
Materials and Methods. Data shown are means ± standard deviations
of triplicate experiments.
|
|
While the propensity of sand fly saliva to inhibit NO production has
been documented previously (9), our results show that this
reduction is a result of saliva interfering with iNOS gene expression.
This effect is probably generated via the inhibition of protein
dephosphorylation events in mouse M
exposed to P. papatasi saliva.
In nature P. papatasi sand flies transmit cutaneous
leishmaniasis by inoculating an estimated 10 to 700 Leishmania
major promastigotes into the skin (31). However,
experimental inoculation of susceptible mice with comparably low
numbers of L. major promastigotes (100 to 500) does not
cause disease but rather promotes immunity (6, 16). Why do
low numbers of fly-transmitted parasites cause disease whereas
syringe-inoculated parasites do not? It has been demonstrated that
P. papatasi salivary gland lysates enhance the
development of cutaneous leishmaniasis lesions (26). One
probable means by which saliva promotes parasite survival in M
is
via the inhibition of NO production. Supportive evidence shows that
inhibition of iNOS expression in the skins of chronically infected
asymptotic resistant mice reactivates latent L. major
infections (24). Therefore, the down regulation of iNOS
expression and the resultant reduction in NO production caused by
P. papatasi saliva may similarly promote proliferation
of amastigotes.
Partial biochemical characterization of the salivary PP-1/2A
inhibitor.
For fractionation, 50 glands were lysed and spun
filtered through Amicon microconcentrator filters as described in
Materials and Methods. The retentate of the different filters and the
3-kDa filtrate were resuspended in HBSS, and two gland equivalents were used for the PP and NO assays. Only the 3-kDa filtrate showed inhibitory activity to PP-1/2A and NO (Fig. 4). The PP inhibition was
dose dependent (data not shown). In addition, the PP-1/2A inhibitor was
soluble in 100% ethanol. It was resistant to boiling for 10 min and
was unaffected by proteases (trypsin and proteinase K) and nucleases
(RNase and DNase). Hence, the PP-1/2A and NO inhibitory activities are
probably mediated by the same small molecule (<3 kDa) which is neither
a polypeptide nor a nucleic acid. Its exact characteristics await
further clarification.
The data presented in this report illustrate the intricate nature of
the mechanisms by which sand fly saliva enhances disease transmission.
Pharmacologically active molecules, such as maxadilan in L. longipalpis or the described PP-1/2A inhibitor in P. papatasi saliva, probably evolved to facilitate blood feeding.
However, as with many other biomolecules, salivary factors also exhibit other activities. In this case, Leishmania parasites have
capitalized on the immunomodulatory effects of certain salivary factors
to facilitate their establishment in the hostile environment of the vertebrate skin.
 |
ACKNOWLEDGMENTS |
This research was supported in part by grant 363/96-1 from The
Israel Science Foundation and by The Bruno Goldberg Foundation (grants
to A.W.). Additional support was provided by National Institutes of
Health grant AI36382 (to G. C. Lanzaro, University of Texas
Medical Branch, Galveston, Tex.) and AID grant TA-MOU-96-C14-142. J.W. is the recipient of a Golda Meir postdoctoral fellowship.
We thank J. M. C. Ribeiro, J. Shlomai, and M. P. Barrett for many useful suggestions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Parasitology, Hebrew University-Hadassah Medical School, P.O. Box
12272, Ein Kerem, Jerusalem 91120, Israel. Phone: 972-2-6757080. Fax: 972-2-6757425. E-mail: Warburg{at}cc.huji.ac.il.
Editor: S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Ashford, R. W.,
P. Desjeux, and P. deRaadt.
1992.
Estimation of populations at risk of infection and number of cases of leishmaniasis.
Parasitol. Today
8:104-105.
[Medline] |
| 2.
|
Bialojan, C., and A. Takai.
1988.
Inhibitory effect of a marine-sponge toxin, okadaic acid on protein phosphatases.
Biochem. J.
256:283-290[Medline].
|
| 3.
|
Bradley, D. J.
1987.
Visceral and post kala azar dermal leishmaniasis, p. 551-582. In
W. Peters, and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. II.
Academic Press, San Diego, Calif.
|
| 4.
|
Cohen, P.
1989.
The structure and regulation of protein phosphatases.
Annu. Rev. Biochem.
58:435-508.
|
| 5.
|
Cohen, P.,
C. F. B. Holmes, and Y. Tsukitani.
1990.
Okadaic acid: a new probe for the study of cellular regulation.
Trends Biochem. Sci.
15:98-102[Medline].
|
| 6.
|
Doherty, M., and R. Coffman.
1996.
Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice.
Exp. Parasitol.
84:124-135[Medline].
|
| 7.
|
Dong, Z.,
X. Yang,
K. Xie,
S. H. Juang,
N. Liansa, and I. J. Fidler.
1995.
Activation of inducible nitric oxide synthase gene in murine macrophages requires protein phosphatase 1 and 2A.
J. Leukocyte Biol.
58:725-732[Abstract].
|
| 8.
|
Green, S. J.,
C. A. Nacy, and M. S. Meltzer.
1991.
Cytokine-induced synthesis of nitrogen oxide in macrophages: a protective host response to Leishmania and other intracellular pathogens.
J. Leukocyte Biol.
50:93-103[Medline].
|
| 9.
|
Hall, L. R., and T. G. Titus.
1995.
Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.
J. Immunol.
155:3501-3506[Abstract].
|
| 10.
|
Haystead, T. J.,
A. T. R. Sim,
D. Carling,
R. C. Honnor,
Y. Tsukitani,
P. Cohen, and D. G. Hardie.
1989.
Effects of the tumor promoter okadaic acid on intracellular protein phosphorylation and metabolism.
Nature
337:78-81[Medline].
|
| 11.
|
Ingebritsen, S. T., and P. Cohen.
1983.
Protein phosphatases: properties and role in cellular regulation.
Science
221:331-333[Abstract/Free Full Text].
|
| 12.
|
Jaffrey, S., and S. Snyder.
1995.
Nitric oside: a neural messenger.
Annu. Rev. Cell Dev. Biol.
11:417-440.
[Medline] |
| 13.
|
Lerner, E. A.,
J. M. C. Ribeiro,
R. J. Nelson, and M. Lerner.
1991.
Isolation of Maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis.
J. Biol. Chem.
266:11234-11236[Abstract/Free Full Text].
|
| 14.
|
Liew, F. Y., and C. A. O'Donnel.
1993.
Immunology of leishmaniasis.
Adv. Parasitol.
32:161-259[Medline].
|
| 15.
|
Lima, H., and R. Titus.
1996.
Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice.
Infect. Immun.
64:5442-5445[Abstract].
|
| 16.
|
Menon, J. N., and P. A. Bretscher.
1996.
Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
Eur. J. Immunol.
26:243-249[Medline].
|
| 17.
|
Modi, G. B., and R. B. Tesh.
1983.
A simple technique for mass rearing Lutzomyia longipalpis and Phlebotomus papatasi.
J. Med. Entomol.
20:568-569[Medline].
|
| 18.
|
Qureshi, A.,
A. Asahina,
M. Ohnuma,
M. Tajima,
R. Granstein, and E. Lerner.
1996.
Immunomodulatory properties of maxadilan, the vasodilator peptide from sand fly salivary gland extracts.
Am. J. Trop. Med. Hyg.
54:665-671.
|
| 19.
|
Reiner, S. L.,
S. Zheng,
D. B. Corry, and R. M. Locksley.
1993.
Constructing polycompetitor cDNAs for quantitative PCR.
J. Immunol. Methods
165:37-46[Medline].
|
| 20.
|
Ribeiro, J. M. C.,
A. Vachereau,
G. B. Modi, and R. B. Tesh.
1989.
A novel vasodilatory peptide from the salivary glands of the sandfly Lutzomyia longipalpis.
Science
243:212-214[Abstract/Free Full Text].
|
| 21.
|
Sacks, D. L., and P. V. Perkins.
1985.
Development of infective stage Leishmania promastigotes within phlebotomine sand flies.
Am. J. Trop. Med. Hyg.
34:456-459.
|
| 22.
|
Samuelson, J.,
E. Lerner,
R. Tesh, and R. Titus.
1991.
A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva.
J. Exp. Med.
173:49-54[Abstract/Free Full Text].
|
| 23.
|
Shelonikar, S., and T. S. Ingebritsen.
1984.
Protein (serine and threonine) phosphatases.
Methods Enzymol.
107:102-107[Medline].
|
| 24.
|
Streger, S.,
N. Donhauser,
H. Thung,
M. Rollinghoff, and C. Bogdan.
1996.
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
J. Exp. Med.
183:1501-1514[Abstract/Free Full Text].
|
| 25.
|
Theodos, C. M.,
J. M. C. Ribeiro, and R. G. Titus.
1991.
Analysis of enhancing effect of sandfly saliva on Leishmania infection in mice.
Infect. Immun.
59:1592-1598[Abstract/Free Full Text].
|
| 26.
|
Theodos, C. M., and R. G. Titus.
1993.
Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro.
Parasite Immunol.
15:481-487[Medline].
|
| 27.
|
Titus, R., and J. M. C. Ribeiro.
1988.
Salivary gland lysates of the sandfly Lutzomyia longipalpis enhance Leishmania infectivity.
Science
239:1306-1308[Abstract/Free Full Text].
|
| 28.
|
Vidal, S. M.,
D. Malo,
K. Vogan,
E. Skamene, and P. Gros.
1993.
Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg.
Cell
73:469-485[Medline].
|
| 29.
|
Walton, B. C.
1987.
American cutaneous and mucocutaneous leishmaniasis, p. 638-653. In
W. Peters, and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. II.
Academic Press, San Diego, Calif.
|
| 29a.
| Warburg, A. Unpublished data.
|
| 30.
|
Warburg, A.,
E. Saraiva,
G. C. Lanzaro,
R. Titus, and F. Neva.
1994.
Saliva of Lutzomyia longipalpis sibling species differs in its composition and propensity to enhance leishmaniasis.
Philos. Trans. R. Soc. Lond. B
354:223-230.
|
| 31.
|
Warburg, A., and Y. Schlein.
1986.
The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major.
Am. J. Trop. Med. Hyg.
35:926-930.
|
Infect Immun, April 1998, p. 1534-1537, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Carregaro, V., Valenzuela, J. G., Cunha, T. M., Verri, W. A. Jr., Grespan, R., Matsumura, G., Ribeiro, J. M. C., Elnaiem, D.-E., Silva, J. S., Cunha, F. Q.
(2008). Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway. J. Leukoc. Biol.
84: 104-114
[Abstract]
[Full Text]
-
Wheat, W. H., Pauken, K. E., Morris, R. V., Titus, R. G.
(2008). Lutzomyia longipalpis Salivary Peptide Maxadilan Alters Murine Dendritic Cell Expression of CD80/86, CCR7, and Cytokine Secretion and Reprograms Dendritic Cell-Mediated Cytokine Release from Cultures Containing Allogeneic T Cells. J. Immunol.
180: 8286-8298
[Abstract]
[Full Text]
-
Brodie, T. M., Smith, M. C., Morris, R. V., Titus, R. G.
(2007). Immunomodulatory Effects of the Lutzomyia longipalpis Salivary Gland Protein Maxadilan on Mouse Macrophages. Infect. Immun.
75: 2359-2365
[Abstract]
[Full Text]
-
Norsworthy, N. B., Sun, J., Elnaiem, D., Lanzaro, G., Soong, L.
(2004). Sand Fly Saliva Enhances Leishmania amazonensis Infection by Modulating Interleukin-10 Production. Infect. Immun.
72: 1240-1247
[Abstract]
[Full Text]
-
Costa, D. J., Favali, C., Clarencio, J., Afonso, L., Conceicao, V., Miranda, J. C., Titus, R. G., Valenzuela, J., Barral-Netto, M., Barral, A., Brodskyn, C. I.
(2004). Lutzomyia longipalpis Salivary Gland Homogenate Impairs Cytokine Production and Costimulatory Molecule Expression on Human Monocytes and Dendritic Cells. Infect. Immun.
72: 1298-1305
[Abstract]
[Full Text]
-
Belkaid, Y., Valenzuela, J. G., Kamhawi, S., Rowton, E., Sacks, D. L., Ribeiro, J. M. C.
(2000). Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly?. Proc. Natl. Acad. Sci. USA
97: 6704-6709
[Abstract]
[Full Text]
-
Ribeiro, J., Katz, O, Pannell, L., Waitumbi, J, Warburg, A
(1999). Salivary glands of the sand fly Phlebotomus papatasi contain pharmacologically active amounts of adenosine and 5'-AMP. J. Exp. Biol.
202: 1551-1559
[Abstract]